Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
Trader Note — 15007 total
Meta Platforms has clawed back $26 in two sessions, closing Tuesday at $570.05 — a 4.9% weekly gain that takes the edge off the worst of the trial-driven selloff, but leaves the stock still 32% below the Street's mean…
Booz Allen Hamilton has extended its drift lower this week, falling another 2.5% to $73.83, but the more interesting development sits inside the short book, where the bear position has collapsed at a pace that stands…
VOO enters the final days of August with a striking divergence: the most dramatic single-session shift in options positioning seen all year, set against a price chart that is quietly steadying after last week's…
Tesla heads into the final days of August in a familiar holding pattern: the Cybercab catalyst that drove a 6% gain last week has already begun to fade, and the stock is giving back ground without any meaningful shift…
JKS is caught in an unusual split this week — the stock fell nearly 6% over five sessions, yet short sellers are actively reducing exposure while options traders pile into calls at an extreme not seen all year. The…
GM enters the final week of August with a striking contradiction at its heart: options traders are the most bullish they have been all year, yet the executives running the company spent the past month selling stock at…
MaxLinear enters the final week of August with a sharp internal contradiction: the stock bounced 5.7% on Tuesday after falling 8.6% over the prior week, yet the founder and CEO just sold more than $21 million of stock…
Suncor Energy enters the back half of the summer with a clear tension at its heart: executives are cashing out near the year's highs while the short sellers who crowded in during July have been quietly walking…
CleanSpark is back at $12.75 after a strong week, yet nearly 29% of the free float remains short — a rare tension between sector momentum and structural skepticism. The positioning story is dominated by that short…
JBT Marel Corporation enters the final week of August with a curious split: short sellers have been quietly rebuilding positions even as the stock edges higher and a fresh analyst initiation points to meaningful upside…
GLD has surged 7.4% this week to $428.07 — its biggest weekly gain in months — and the options market, which was already leaning bullish when the previous note was filed last Tuesday at $398.55, has only grown more…
The story that dominated the last KBE note — shorts steadily retreating — has reversed in a single week. Seven days ago, the headline was covering. Shares short had fallen roughly 12% from the July peak, and the…
KIE, the SPDR S&P Insurance ETF, enters the final week of August with a notable contradiction at its core: short interest is near its highest level in months, yet the lending market is far more relaxed than those…
KRE enters the final week of August with a striking contradiction at its core: short interest has climbed sharply back toward multi-week highs, yet the borrow market just swung from near-total tightness to its loosest…
QQQ closed Tuesday at $710.72 — down less than 1% on the week — but the positioning data underneath the surface is anything but quiet, with short sellers executing their sharpest single-day cover of the entire…
CME Group has continued to grind higher since the Deutsche Bank downgrade last week, and the most notable development this week is not what bears are doing — it's what they're stopping doing. Short sellers have been…
MOO heads into the final week of August with a notable split: the ETF is up 4.4% on the week, yet options positioning has abruptly turned more defensive than at any point in recent memory. The options signal is the…
Quantum Computing Inc. ends the week with a fresh analyst upgrade on one side and an utterly frozen lending market on the other — the same extreme tension flagged three days ago, now with new Street activity adding a…
Macy's stock has entered a new phase after its Q2 earnings release, with short sellers cutting positions and the stock drifting lower — a combination that tells a more complicated post-print story than the pre-release…
Jazz Pharmaceuticals enters the final days of August with a rare alignment: the Street is lifting targets in unison, the stock is up on the week, and options traders are quietly hedging — a setup that signals…
